WHEREAS:Registration Rights Agreement • January 19th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledJanuary 19th, 2001 Company Industry Jurisdiction
EXHIBIT 10.39 THIS WARRANT (THIS "WARRANT") HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAW. NEITHER THIS WARRANT NOR ANY SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF NOR ANY...Warrant Agreement • May 10th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledMay 10th, 2001 Company Industry Jurisdiction
] Brackets indicate information omitted from this exhibit pursuant to a confidential treatment request and filed separately with the SEC. LICENSE AGREEMENT by and between UNIGENE LABORATORIES, INC.License Agreement • August 4th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledAugust 4th, 1997 Company Industry Jurisdiction
EXHIBIT 10.42 SETTLEMENT AGREEMENT This SETTLEMENT AGREEMENT ("Agreement") is entered into the 9th day of April 2002, by and among Unigene Laboratories, Inc., a Delaware corporation (the "Company") and The Tail Wind Fund, Ltd., a British Virgin...Settlement Agreement • April 12th, 2002 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledApril 12th, 2002 Company Industry Jurisdiction
WHEREAS:Common Stock Purchase Agreement • April 27th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledApril 27th, 2001 Company Industry Jurisdiction
EXHIBIT QRegistration Rights Agreement • January 10th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Delaware
Contract Type FiledJanuary 10th, 1997 Company Industry Jurisdiction
EXHIBIT 10.19 EXECUTION COPY AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT by and amongSecurities Purchase Agreement • January 10th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledJanuary 10th, 1997 Company Industry Jurisdiction
andRights Agreement • December 23rd, 2002 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledDecember 23rd, 2002 Company Industry Jurisdiction
WHEREAS:Registration Rights Agreement • October 10th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledOctober 10th, 2003 Company Industry Jurisdiction
Exhibit 10.3 SUBORDINATION AGREEMENT THIS SUBORDINATION AGREEMENT (the "Agreement") is entered into this 13th day of July by and among Unigene Laboratories, Inc., a Delaware corporation (the "Company"), Jay Levy, a resident of New Jersey, Warren P....Subordination Agreement • November 19th, 1999 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledNovember 19th, 1999 Company Industry Jurisdiction
EXHIBIT 10.37 THIS WARRANT (THIS "WARRANT") HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAW. NEITHER THIS WARRANT NOR ANY SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF NOR ANY...Warrant Agreement • April 27th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledApril 27th, 2001 Company Industry Jurisdiction
ARTICLE I PURCHASE AND SALE OF STOCKStock Purchase Agreement • August 4th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledAugust 4th, 1997 Company Industry Jurisdiction
EXHIBIT 10.1 PURCHASE AGREEMENT THIS PURCHASE AGREEMENT ("Agreement") is made as of the 29th day of June, 1998 by and between Unigene Laboratories, Inc., a Delaware corporation (the "Company"), and The Tail Wind Fund, Ltd., a British Virgin Islands...Purchase Agreement • August 14th, 1998 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Delaware
Contract Type FiledAugust 14th, 1998 Company Industry Jurisdiction
Exhibit 10.4 MORTGAGE AND SECURITY AGREEMENT THIS MORTGAGE made this 13th day of July, 1999, between UNIGENE LABORATORIES, INC., a Delaware corporation, having an office at 110 Little Falls Road, Fairfield, New Jersey 07004 (herein called the...Mortgage and Security Agreement • November 19th, 1999 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledNovember 19th, 1999 Company Industry
Exhibit 10.38 PATENT SECURITY AGREEMENT THIS PATENT SECURITY AGREEMENT (the "Agreement") is entered into as of this 13th day of March, 2001 by and between UNIGENE LABORATORIES, INC., a Delaware corporation, having its principal place of business at...Patent Security Agreement • December 12th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledDecember 12th, 2001 Company Industry Jurisdiction
EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT, dated as of January 1, 2000 (the "Effective Date"), is entered into by and between Unigene Laboratories, Inc., a Delaware corporation having offices at 110 Little Falls Road, Fairfield, N.J. 07004 (the...Employment Agreement • March 31st, 2000 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledMarch 31st, 2000 Company Industry
Exhibit 10.1 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as **. A complete version of this exhibit has been...License and Development Agreement • January 9th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledJanuary 9th, 2003 Company Industry Jurisdiction
Exhibit 10.2 AMENDED AND RESTATED SECURITY AGREEMENT THIS AMENDED AND RESTATED SECURITY AGREEMENT (the "Agreement") is entered into this 13th day of July, 1999 by and among UNIGENE LABORATORIES, INC., a Delaware corporation, having its principal place...Security Agreement • November 19th, 1999 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledNovember 19th, 1999 Company Industry Jurisdiction
1,600,000.00 July 13, 1999 THIS AMENDED AND RESTATED SECURED NOTE (the "Note") is made as of the 13th day of July, 1999 by Unigene Laboratories, Inc., a Delaware corporation (the "Company"), in favor and for the benefit of Jay Levy, a resident of New...Secured Note • November 19th, 1999 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledNovember 19th, 1999 Company Industry Jurisdiction
WHEREAS:Registration Rights Agreement • May 10th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledMay 10th, 2001 Company Industry Jurisdiction
EXHIBIT 10.1 JOINT VENTURE CONTRACT on the establishment of "SHIJIAZHUANG - UNIGENE PHARMACEUTICAL CORPORATION LIMITED"Joint Venture Contract • August 14th, 2000 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledAugust 14th, 2000 Company Industry
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 6th, 2008 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledOctober 6th, 2008 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 30, 2008, is entered into by and among Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and the lender(s) listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).
UNIGENE LABORATORIES, INC. 110 Little Falls Road Fairfield, New Jersey 07004Common Stock Purchase Agreement • December 12th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledDecember 12th, 2001 Company Industry
WHEREAS:Registration Rights Agreement • May 10th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledMay 10th, 2001 Company Industry Jurisdiction
Schedule 10.20 -------------- Exhibit 10.20 is the form of Regulation S Securities Subscription Agreement entered into by the Company and each of 22 subscribers for the sale and purchase of an aggregate principal amount of $9.08 million of the...Regulation S Securities Subscription Agreement • January 10th, 1997 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Delaware
Contract Type FiledJanuary 10th, 1997 Company Industry Jurisdiction
110 Little Falls RoadCommon Stock Purchase Agreement • November 19th, 2001 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledNovember 19th, 2001 Company Industry
EMPLOYMENT AGREEMENTEmployment Agreement • October 3rd, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledOctober 3rd, 2012 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (“Agreement”), dated as of September 27, 2012, is entered into by and between Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and Nozer Mehta (the “Executive”).
EXHIBIT 10.3 AMENDMENT TO LOAN AGREEMENT AND SECURITY AGREEMENT This Amendment to Loan Agreement and Security Agreement ("Amendment") made this 25th day of June, 1999 by and between Unigene Laboratories, Inc., a Delaware corporation authorized to do...Loan Agreement and Security Agreement • August 16th, 1999 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledAugust 16th, 1999 Company Industry
WHEREAS:Common Stock Purchase Agreement • October 10th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • Illinois
Contract Type FiledOctober 10th, 2003 Company Industry Jurisdiction
EMPLOYMENT AGREEMENTEmployment Agreement • June 12th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledJune 12th, 2012 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (“Agreement”), dated as of June 8, 2012 (the “Effective Date”), is entered into by and between Unigene Laboratories, Inc., a Delaware corporation (the “Company”), and Ashleigh Palmer (the “Executive”).
WITNESSETH:Director Stock Option Agreement • April 18th, 2003 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledApril 18th, 2003 Company Industry Jurisdiction
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 16th, 2009 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledMarch 16th, 2009 Company IndustryTHIS FIRST AMENDMENT to the Employment Agreement, dated as of January 1, 2000 (the “Agreement”) is made as of this 22nd day of December, 2008 by and between UNIGENE LABORATORIES, INC. (the “Company”) and Warren Levy (the “Executive”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 22nd, 2006 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledMarch 22nd, 2006 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 17, 2006, by and among Unigene Laboratories Inc., a Delaware corporation, with headquarters located at 110 Little Falls Road, Fairfield, New Jersey 07004 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • August 9th, 2012 • Unigene Laboratories Inc • Medicinal chemicals & botanical products
Contract Type FiledAugust 9th, 2012 Company IndustryTHIS CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (the “Separation Agreement”) is made and entered into by and between David Moskowitz (“Employee”) and Unigene Laboratories, Inc. (“Unigene” or the “Company”).
UNIGENE LABORATORIES, INC. AMENDED AND RESTATED SECURED PROMISSORY NOTESecured Promissory Note • October 6th, 2008 • Unigene Laboratories Inc • Medicinal chemicals & botanical products • New Jersey
Contract Type FiledOctober 6th, 2008 Company Industry JurisdictionUCC-1 Financing Statement filed in New Jersey on 6/26/01 in favor of GE Capital Colonial Pacific Leasing (assignee of lessor Genesis Commercial Capital, LLC) regarding: Equipment/Lease No. 01328-01